Pulsatile Growth Hormone Release
Growth Hormone
Gold-standard GH combo for synergistic fat loss, muscle gain, and deeper sleep.
$299 / month
Starting at $229/mo with 3-month supply + WELCOME10
About
CJC-1295/Ipamorelin is a two-peptide combination that nudges your own pituitary to release more growth hormone. CJC-1295 is a modified GHRH analog with an extended half-life — it keeps the "release GH" signal switched on for days. Ipamorelin is a selective GH secretagogue that triggers clean, pulsed GH release without touching cortisol, prolactin, or appetite.
Used together, the two pathways amplify each other: published work puts combined GH output at roughly 3 to 5 times what either peptide produces alone. Because the release stays pulsatile — the way your body does it naturally — you get the body-composition, recovery, and sleep benefits associated with GH optimization with less of the risk of flat, around-the-clock dosing.
PeRx ships CJC-1295/Ipamorelin fully reconstituted from an FDA-registered 503A pharmacy. No mixing — insulin syringes and a step-by-step guide arrive in the box. It is given as a single evening subcutaneous injection on a provider-determined schedule.
Dramatically improves deep sleep quality. GH releases during sleep, and this combo amplifies the natural cycle.
Real fat loss with real lean muscle gain. Body composition changes show up in 4 to 8 weeks.
Cuts recovery time between workouts in half. Elevated GH speeds up tissue repair and muscle protein synthesis.
Visible skin elasticity. Smoother fine lines. Better hair. GH is the body’s main driver of collagen.
All-day energy and mental clarity. No more afternoon crashes or the brain fog of declining GH.
Why people explore CJC-1295/Ipamorelin
Growth hormone releases in your deepest sleep stages, and CJC-1295/Ipamorelin amplifies that natural pulse. Deeper sleep and better mornings are usually the first thing people notice — often within the first 1–2 weeks.
Evening dosing on an empty stomach lines the peptide pulse up with your natural nighttime GH release.
Sustained IGF-1 drives more fat breakdown and more lean-tissue protein synthesis at the same time. Visible body-composition shifts — especially around the midsection — typically show up in the 4–8 week window.
Elevated GH speeds tissue repair and muscle protein synthesis, so you bounce back faster between hard sessions — and the collagen boost shows up in skin, hair, and connective tissue too.
What it helps with
Ideal for
Adults seeking body composition changes · Those wanting fat loss with muscle preservation · Athletes looking for recovery support · Individuals over 35 with declining GH
The science
CJC-1295 (no-DAC, Modified GRF 1-29) binds GHRH receptors with a short, roughly 30-minute action that primes the pituitary while keeping release pulsatile. Ipamorelin selectively binds ghrelin receptors to trigger a clean GH pulse without affecting cortisol or prolactin. The dual-pathway approach amplifies natural GH output while preserving the body's feedback mechanisms.
CJC-1295/Ipamorelin is given as a single subcutaneous injection in the evening, on an empty stomach — the timing stacks the peptide-driven pulse on top of your natural nighttime GH release.
CJC-1295 binds GHRH receptors with an extended half-life for continuous GH stimulation; Ipamorelin selectively binds ghrelin receptors to add clean GH pulses without raising cortisol or prolactin. Together the two pathways amplify natural GH output while preserving the body’s feedback rhythm.
Over the following weeks most people notice deeper sleep first (weeks 1–2), then faster recovery and early fat loss (weeks 3–6), then visible body-composition changes (weeks 6–10). Your provider rechecks IGF-1 along the way to keep you in a healthy range.
What the research shows
2–10×
GH increase from a single CJC-1295 dose
~30 min
Pulsatile action, dosed daily (no-DAC)
3–5×
More GH output than either peptide alone
1.5–3×
IGF-1 elevation with consistent dosing
Our medication is delivered from a state-licensed pharmacy in our network, right to your door when you need it.
Our pharmacies perform third-party testing through FDA and DEA registered labs to run quality control checks for every compounded lot. They test four key characteristics associated with quality and safety.
Performed on every batch to confirm the active ingredient is present at the labeled concentration. Your vial contains exactly what it should.
Tests for the presence of bacteria, fungi, and other microorganisms. Every batch is tested and must meet the requirements of USP 797.1.
Screens for bacterial endotoxins that can cause fever or adverse reactions. Every batch is tested and must not exceed the threshold limits defined in USP 85.
Assesses the acid/base balance to ensure minimal irritation upon injection and confirm the solution is within the correct range for subcutaneous administration.
What to expect
Week 1–2
What you may notice: Better sleep first and foremost — falling asleep faster, sleeping deeper, waking up actually rested. More daytime energy. Some people get vivid dreams.
What’s happening: GH and IGF-1 are starting to climb. Evening dosing lines up with your natural sleep-phase GH release, which is why sleep improves first.
Week 3–6
What you may notice: Faster recovery between workouts. Less soreness. Early fat loss, especially around the midsection. Skin starts looking better.
What’s happening: Sustained IGF-1 is driving more protein synthesis and fat breakdown. Collagen production is increasing, which affects skin, hair, and connective tissue.
Week 6–10
What you may notice: Visible fat loss. Better muscle definition. Strength up, endurance up. This is when other people start asking what you’re doing differently.
What’s happening: Weeks of elevated GH are now producing measurable body-composition change — more lean mass, less fat mass.
Week 10–12+
What you may notice: Significant improvements across body composition, energy, recovery, and sleep. You feel and look different.
What’s happening: Your provider reassesses IGF-1 and overall response. Some people continue, some cycle off for a rest period, some move to a maintenance protocol.
Comparison
Both boost growth hormone — here’s which one fits.
| CJC-1295/Ipamorelin | Tesamorelin | |
|---|---|---|
| Best for | Body composition, recovery, sleep, and overall GH optimization | Targeted visceral (belly) fat reduction — the only GHRH analog FDA-approved for it |
| How it works | Two pathways — a GHRH analog (CJC-1295) plus a selective GH secretagogue (Ipamorelin) | A single, stabilized GHRH analog |
| GH boost | Strong — the dual pathway produces 3–5× more GH than either peptide alone | Strong and steady — a robust GHRH-driven pulse |
| Best if you want | Broad GH benefits: sleep, recovery, lean mass, fat loss | To zero in on stubborn visceral fat specifically |
| Can combine? | Yes — works alongside Tesamorelin or on its own | Yes — pairs with CJC-1295/Ipamorelin |
What’s included
From the moment you finish your assessment to your first dose, every step is handled by licensed providers and U.S. pharmacies.
New to self-injection? See the step-by-step guideFAQ
Patient reviews
CJC/Ipa made a noticeable difference in my recovery and metabolism support. My energy usually fluctuates day to day, but this made my energy felt a bit more predictable once I got into a rhythm. I also became noticeably leaner after a month of using.
This is not medical advice. Every patient's experience differs and not everyone qualifies for peptide therapy. All reviews are from verified PeRx patients and are published as submitted. Peptide therapy requires a valid prescription from a licensed provider.
Your safety, first
All prescriptions are issued by a licensed US provider after reviewing your intake.
Side effects, contraindications, and what to discuss with your provider before starting.
Read safety informationSupporting research
A selection of peer-reviewed work on CJC-1295/Ipamorelin. Browse the full literature on PubMed and Google Scholar for ongoing research.
Sustained GH and IGF-1 elevation in humans (CJC-1295)
Teichman SL et al. J Clin Endocrinol Metab. 2006;91(3):799–805.Ipamorelin: the first selective GH secretagogue
Raun K et al. Eur J Endocrinol. 1998;139(5):552–561.GH secretagogues and body composition (review)
Sigalos JT & Pastuszak AW. Peptide therapeutics review, 2020.The statements on this page have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The FDA does not review or approve compounded medications for safety or effectiveness. Off-label use must be prescribed and supervised by a licensed provider.
You may also be interested in
Keep exploring
Last updated April 2026
Medical disclaimer
The information provided on this page is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Peptide therapy requires a valid prescription from a licensed healthcare provider. Individual results may vary. No specific outcomes are guaranteed.
The peptides on this site are not FDA-approved. They are compounded by licensed pharmacies under provider supervision. Certain peptides are prohibited by WADA and major sports organizations. Statements on this page have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease.
Take our 2-minute assessment. A licensed US provider reviews and, if appropriate, prescribes a protocol shipped to your door.
$299 / month
Starting at $229/mo with 3-month supply + WELCOME10
